Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis

Diazoxide is the first-line drug for treating hyperinsulinism and the only pharmacological agent approved for hyperinsulinism by the Federal Drug Administration. This systemic review and meta-analysis aimed to investigate the efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaohong, Feng, Lifang, Yao, Hui, Yang, Luhong, Qin, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877589/
https://www.ncbi.nlm.nih.gov/pubmed/33571197
http://dx.doi.org/10.1371/journal.pone.0246463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877589/
https://www.ncbi.nlm.nih.gov/pubmed/33571197
http://dx.doi.org/10.1371/journal.pone.0246463

Ejemplares similares